Proprietary Delivery Technologies
Three clean-label platforms behind ModernVEDA's ingredients — designed around release profile, format and a simple, plant-based label.
Three Delivery Platforms
CITRAP20™
Citrus-fibre matrix designed for gradual, sustained release. Used in CurcXR and CaffXR™.
Explore CITRAP20™ →
VOL Technology
Oil-based, softgel-ready ashwagandha format. Used in SomVOL.
Explore VOL Technology →
VedaBIO‑X
Dual-release platform pairing immediate and extended release. Used in CurcIR.
Explore VedaBIO‑X →
Extraction Methods
We select the extraction route for each botanical to protect its active profile and meet the residual-solvent limits of target markets.
| Solvent Extraction | Food-grade solvents with full residual-solvent testing |
| Water Extraction | For water-soluble fractions |
| Supercritical CO₂ | Solvent-free extraction of lipophilic actives |
Platforms Studied in a Published Human Trial
CurcXR (CITRAP20™) and CurcIR (VedaBIO‑X) were evaluated in a published, randomised, double-blind, placebo-controlled study in 100 adults over 8 weeks. SomVOL (VOL Technology) is in a registered clinical trial.
Delivery Technologies — Common Questions
What delivery technologies does ModernVEDA offer?
CITRAP20™ (citrus-fibre sustained release), VOL Technology (oil-based ashwagandha format) and VedaBIO‑X (dual release).
Are the platforms clean label?
Yes. All three platforms are plant-based, Non-GMO and vegan, with no synthetic excipients.
Which platform suits softgels?
VOL Technology, used in SomVOL, is supplied in an oil-based, softgel-ready format.
Which platforms suit capsules and tablets?
CITRAP20™ and VedaBIO‑X ingredients are powders suited to capsules, tablets and powder blends.
Find the Right Platform for Your Formulation
Tell us your format, target market and volumes. Our team will personally contact you within 1–2 business days.